Coding Ahead
CasePilot
Medical Coding Assistant
Case2Code
Search and Code Lookup Tool
RedactPHI
HIPAA-Compliant PHI Redaction
DetectICD10CM
ICD-10-CM Code Detection
Log in Register free account
1 code page views remaining. Guest accounts are limited to 1 page view. Register free account to get 5 more views.
Log in Register free account

Official Description

Fibrinolysins or coagulopathy screen, interpretation and report

© Copyright 2025 American Medical Association. All rights reserved.

Common Language Description

The CPT® Code 85390 refers to the interpretation and reporting of fibrinolysins or coagulopathy screening tests. This procedure involves a detailed analysis conducted by a pathologist or a qualified professional, who evaluates the results of fibrin or coagulation studies. The interpretation is crucial for understanding the patient's coagulation status, which can be affected by various medical conditions. The request for such an interpretive report may originate from the attending physician or may be established as a standing order within a hospital or care facility. The resulting report is comprehensive and tailored to the individual patient, containing specific diagnostic information that is essential for guiding treatment strategies and determining future testing options. This ensures that healthcare providers have the necessary insights to make informed decisions regarding patient care and management of coagulation disorders.

© Copyright 2025 Coding Ahead. All rights reserved.

1. Indications

The interpretation and report of fibrinolysins or coagulopathy screening tests are indicated in various clinical scenarios where assessment of the coagulation system is necessary. These indications may include, but are not limited to, the following:

  • Evaluation of bleeding disorders to determine the underlying cause of excessive bleeding or bruising in patients.
  • Monitoring of anticoagulation therapy to ensure that patients receiving blood-thinning medications are within therapeutic ranges and to adjust dosages as needed.
  • Assessment of thrombotic conditions to evaluate the risk of thrombosis in patients with a history of blood clots or related complications.
  • Preoperative assessment to identify any potential coagulation issues that may increase the risk of bleeding during surgical procedures.

2. Procedure

The procedure for obtaining an interpretive report of fibrinolysins or coagulopathy screening involves several key steps, which are outlined as follows:

  • Step 1: Sample Collection - A blood sample is collected from the patient, typically through venipuncture. This sample is essential for conducting various coagulation tests that will be analyzed.
  • Step 2: Laboratory Analysis - The collected blood sample is sent to a laboratory where it undergoes a series of tests to evaluate the coagulation factors and fibrinolytic activity. These tests may include prothrombin time (PT), activated partial thromboplastin time (aPTT), and fibrinogen levels, among others.
  • Step 3: Interpretation of Results - A pathologist or qualified professional reviews the laboratory results, considering the patient's clinical history and any relevant symptoms. This interpretation is critical for understanding the patient's coagulation status.
  • Step 4: Report Generation - A detailed written report is generated, which includes the interpretation of the test results, patient-specific diagnostic information, and recommendations for treatment strategies and future testing options.

3. Post-Procedure

After the completion of the fibrinolysins or coagulopathy screening and the generation of the interpretive report, several post-procedure considerations are important. The healthcare provider will review the report with the patient, discussing the findings and their implications for the patient's health. Based on the results, the provider may recommend further testing or adjustments to any ongoing treatment plans. Additionally, the report may guide the management of any identified coagulation disorders, ensuring that appropriate interventions are implemented to mitigate risks associated with bleeding or thrombosis. Continuous monitoring and follow-up may be necessary, depending on the patient's condition and the outcomes of the initial tests.

Short Descr FIBRINOLYSINS SCREEN I&R
Medium Descr FIBRINOLYSINS/COAGULOPATHY SCREEN INTERP&REPOR
Long Descr Fibrinolysins or coagulopathy screen, interpretation and report
Status Code Active Code
Global Days XXX - Global Concept Does Not Apply
PC/TC Indicator (26, TC) 6 - Laboratory Physician Interpretation Code
Multiple Procedures (51) 0 - No payment adjustment rules for multiple procedures apply.
Bilateral Surgery (50) 0 - 150% payment adjustment for bilateral procedures does NOT apply.
Physician Supervisions 09 - Concept does not apply.
Assistant Surgeon (80, 82) 0 - Payment restriction for assistants at surgery applies to this procedure...
Co-Surgeons (62) 0 - Co-surgeons not permitted for this procedure.
Team Surgery (66) 0 - Team surgeons not permitted for this procedure.
Diagnostic Imaging Family 99 - Concept Does Not Apply
CLIA Waived (QW) No
APC Status Indicator Conditionally packaged laboratory tests
Type of Service (TOS) 5 - Diagnostic Laboratory
Berenson-Eggers TOS (BETOS) T1H - Lab tests - other (non-Medicare fee schedule)
MUE 3
CCS Clinical Classification 233 - Laboratory - Chemistry and Hematology
26 Professional component: certain procedures are a combination of a physician or other qualified health care professional component and a technical component. when the physician or other qualified health care professional component is reported separately, the service may be identified by adding modifier 26 to the usual procedure number.
59 Distinct procedural service: under certain circumstances, it may be necessary to indicate that a procedure or service was distinct or independent from other non-e/m services performed on the same day. modifier 59 is used to identify procedures/services, other than e/m services, that are not normally reported together, but are appropriate under the circumstances. documentation must support a different session, different procedure or surgery, different site or organ system, separate incision/excision, separate lesion, or separate injury (or area of injury in extensive injuries) not ordinarily encountered or performed on the same day by the same individual. however, when another already established modifier is appropriate it should be used rather than modifier 59. only if no more descriptive modifier is available, and the use of modifier 59 best explains the circumstances, should modifier 59 be used. note: modifier 59 should not be appended to an e/m service. to report a separate and distinct e/m service with a non-e/m service performed on the same date, see modifier 25.
GC This service has been performed in part by a resident under the direction of a teaching physician
91 Repeat clinical diagnostic laboratory test: in the course of treatment of the patient, it may be necessary to repeat the same laboratory test on the same day to obtain subsequent (multiple) test results. under these circumstances, the laboratory test performed can be identified by its usual procedure number and the addition of modifier 91. note: this modifier may not be used when tests are rerun to confirm initial results; due to testing problems with specimens or equipment; or for any other reason when a normal, one-time, reportable result is all that is required. this modifier may not be used when other code(s) describe a series of test results (eg, glucose tolerance tests, evocative/suppression testing). this modifier may only be used for laboratory test(s) performed more than once on the same day on the same patient.
90 Reference (outside) laboratory: when laboratory procedures are performed by a party other than the treating or reporting physician or other qualified health care professional, the procedure may be identified by adding modifier 90 to the usual procedure number.
X5 Diagnostic services requested by another clinician: for reporting services by a clinician who furnishes care to the patient only as requested by another clinician or subsequent and related services requested by another clinician; this modifier is reported for patient relationships that may not be adequately captured by the above alternative categories; reporting clinician service examples include but are not limited to, the radiologist's interpretation of an imaging study requested by another clinician
76 Repeat procedure or service by same physician or other qualified health care professional: it may be necessary to indicate that a procedure or service was repeated by the same physician or other qualified health care professional subsequent to the original procedure or service. this circumstance may be reported by adding modifier 76 to the repeated procedure or service. note: this modifier should not be appended to an e/m service.
77 Repeat procedure by another physician or other qualified health care professional: it may be necessary to indicate that a basic procedure or service was repeated by another physician or other qualified health care professional subsequent to the original procedure or service. this circumstance may be reported by adding modifier 77 to the repeated procedure or service. note: this modifier should not be appended to an e/m service.
95 Synchronous telemedicine service rendered via a real-time interactive audio and video telecommunications system: synchronous telemedicine service is defined as a real-time interaction between a physician or other qualified health care professional and a patient who is located at a distant site from the physician or other qualified health care professional. the totality of the communication of information exchanged between the physician or other qualified health care professional and the patient during the course of the synchronous telemedicine service must be of an amount and nature that would be sufficient to meet the key components and/or requirements of the same service when rendered via a face-to-face interaction. modifier 95 may only be appended to the services listed in appendix p. appendix p is the list of cpt codes for services that are typically performed face-to-face, but may be rendered via a real-time (synchronous) interactive audio and video telecommunications system.
AQ Physician providing a service in an unlisted health professional shortage area (hpsa)
CC Procedure code change (use 'cc' when the procedure code submitted was changed either for administrative reasons or because an incorrect code was filed)
CR Catastrophe/disaster related
GA Waiver of liability statement issued as required by payer policy, individual case
GW Service not related to the hospice patient's terminal condition
GX Notice of liability issued, voluntary under payer policy
Q1 Routine clinical service provided in a clinical research study that is in an approved clinical research study
Q3 Live kidney donor surgery and related services
XE Separate encounter, a service that is distinct because it occurred during a separate encounter
XP Separate practitioner, a service that is distinct because it was performed by a different practitioner
XS Separate structure, a service that is distinct because it was performed on a separate organ/structure
XU Unusual non-overlapping service, the use of a service that is distinct because it does not overlap usual components of the main service
Date
Action
Notes
2013-01-01 Changed Description Changed
Pre-1990 Added Code added.
Code
Description
Code
Description
CasePilot

Get instant expert-level medical coding assistance.

Ask about:
CPT Codes Guidelines Modifiers Crosswalks NCCI Edits Compliance Medicare Coverage
Example: "What is CPT code 99213?" or "Guidelines for E/M services"